How Staphylococcus aureus Resists Lysozyme
Author Information
Author(s): Herbert Silvia, Bera Agnieszka, Nerz Christiane, Kraus Dirk, Peschel Andreas, Goerke Christiane, Meehl Michael, Cheung Ambrose, Götz Friedrich
Primary Institution: University of Tübingen
Hypothesis
The study investigates the genetic basis of Staphylococcus aureus resistance to lysozyme's muramidase and cationic antimicrobial peptide activities.
Conclusion
The research demonstrates that resistance to lysozyme in Staphylococcus aureus involves distinct genetic mechanisms for its muramidase and cationic antimicrobial peptide activities.
Supporting Evidence
- The oatA/dltA double mutant showed the highest sensitivity to lysozyme, indicating a synergistic effect of the two resistance mechanisms.
- Transcriptome analysis revealed that GraRS controls 248 genes, including those involved in resistance to lysozyme.
- The graRS mutant was more susceptible to cationic antimicrobial peptides than the wild type, highlighting the role of GraRS in resistance.
Takeaway
Staphylococcus aureus has special genes that help it survive attacks from a protein called lysozyme, which usually helps our bodies fight off bacteria.
Methodology
The study used genetic mutants of Staphylococcus aureus to analyze their susceptibility to lysozyme and cationic antimicrobial peptides, along with transcriptome analysis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website